4//SEC Filing
CAPRICOR THERAPEUTICS, INC. 4
Accession 0001144204-16-089007
$CAPRCIK 0001133869operating
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 9:33 PM ET
Size
7.6 KB
Accession
0001144204-16-089007
Insider Transaction Report
Form 4
GERSHELL LELAND
CHIEF FINANCIAL OFFICER
Transactions
- Purchase
Warrants (Right to Buy)
2016-03-16$0.13/sh+1,050$131→ 1,050 totalExercise: $4.50From: 2016-09-17Exp: 2019-03-16→ Common Stock (1,050 underlying) - Purchase
Common Stock
2016-03-16$2.40/sh+2,100$5,040→ 2,100 total
Footnotes (1)
- [F1]The Reporting Person entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which the Reporting Person, on March 16, 2016, purchased (i) 2,100 shares of the Issuer's common stock at a purchase price of $2.40 per share, and (ii) warrants to purchase up to an aggregate of 1,050 shares of the Issuer's common stock at a purchase price of $0.125 per share issuable upon exercise of the warrants, for an aggregate purchase price of approximately $5,171.
Documents
Issuer
CAPRICOR THERAPEUTICS, INC.
CIK 0001133869
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001133869
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 9:33 PM ET
- Size
- 7.6 KB